Abstract
N-Phenylpyrazine-2-carboxamides (anilides of pyrazinoic acids with simple substituents in various positions) were previously shown to possess significant biological activities in vitro, markedly anti-mycobacterial and photosynthesis-inhibiting activity. Based on structure-activity relationships (SAR) extracted from previously published series, 25 new anilides of non-substituted pyrazinoic acid (POA), 5-CH3-POA, 6-Cl-POA, 5-tert-butyl-POA and 5-tert-butyl-6-Cl-POA were designed and synthesised.
The phenyl part was substituted with simple hydrophobic substituents chosen from methyl and halogens. 5-tert-Butyl-N-(5-fluoro-2-methylphenyl) pyrazine-2-carboxamide (9), N-(3-chloro-4-methylphenyl)-5-methylpyrazine-2-carboxamide (12), 6-chloro-N-(3-chloro-4-methylphenyl) pyrazine-2-carboxamide (13) and 6-chloro-N-(5-iodo-2-methylphenyl) pyrazine- 2-carboxamide (18) possessed whole cell anti-mycobacterial activity in vitro against Mycobacterium tuberculosis H37Rv with minimum inhibitory concentration (MIC) of around 10 mu M. Importantly, no cytotoxicity in the HepG2 model was detected in vitro at the concentrations tested and the estimated IC50 values were in hundreds of mu M, indicating promising selectivity.
N-(3-Chloro-4-methylphenyl) pyrazine-2-carboxamide (11) and N-(4-chloro-2-iodophenyl) pyrazine-2-carboxamide (21) exerted significant activity against Mycobacterium kansasii with MIC 12.6 mu M and 8.7 mu M, respectively. No activity was detected against Mycobacterium avium.
SAR were in accordance with those observed for the derivatives previously published.